Valenzano; Kenneth

Patent Applications and Registrations

Patent applications and USPTO patent grants for Valenzano; Kenneth.The latest application filed is for "dosing regimens for the treatment of fabry disease".

Company Profile

3.12.11

Valenzano; Kenneth - East Brunswick NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
High concentration alpha-glucosidase compositions for the treatment of Pompe disease Grant 11,278,599 - Valenzano , et al. March 22, 2	2022-03-22
Dosing Regimens For The Treatment Of Fabry Disease App 20200268890 - Greene; Douglas Stuart ; et al.	2020-08-27
High Concentration Alpha-glucosidase Compositions For The Treatment Of Pompe Disease App 20200188494 - Valenzano; Kenneth ; et al.	2020-06-18
High concentration alpha-glucosidase compositions for the treatment of pompe disease Grant 10,512,677 - Valenzano , et al. Dec	2019-12-24
.alpha.-galactosidase A and 1-deoxygalactonojirimycin co-formulation Grant 10,357,548 - Khanna , et al. July 23, 2	2019-07-23
High Concentration Alpha-glucosidase Compositions For The Treatment Of Pompe Disease App 20180360928 - Valenzano; Kenneth ; et al.	2018-12-20
Alpha-galactosidase A and 1-deoxygalactonojirimycin co-formulation for the treatment of fabry disease Grant 10,155,027 - Khanna , et al. Dec	2018-12-18
High concentration alpha-glucosidase compositions for the treatment of Pompe disease Grant 10,046,033 - Valenzano , et al. August 14, 2	2018-08-14
Dosing Regimens For The Treatment Of Fabry Disease App 20180153999 - Greene; Douglas Stuart ; et al.	2018-06-07
Pharmacological chaperones for treating obesity Grant 9,937,165 - Fan , et al. April 10, 2	2018-04-10
Method for treating cerebral amyloid angiopathy using pharmacological chaperones to increase the activity of gangliosidases Grant 9,931,353 - Wustman , et al. April 3, 2	2018-04-03
Alpha-Galactosidase A And 1-Deoxygalactonojirimycin Co-Formulation App 20170360901 - Khanna; Richie ; et al.	2017-12-21
Alpha-Galactosidase A And 1-Deoxygalactonojirimycin Co-Formulation For The Treatment of Fabry Disease App 20170209548 - Khanna; Richie ; et al.	2017-07-27
High Concentration Alpha-Glucosidase Compositions For The Treatment Of Pompe Disease App 20170056483 - Valenzano; Kenneth ; et al.	2017-03-02
Pharmacological Chaperones for Treating Obesity App 20160287581 - Fan; Jian-Qiang ; et al.	2016-10-06
Pharmacological chaperones for treating obesity Grant 9,381,194 - Fan , et al. July 5, 2	2016-07-05
High concentration .alpha.-glucosidase compositions for the treatment of Pompe disease Grant 9,303,249 - Valenzano , et al. April 5, 2	2016-04-05
Method for Treating Cerebral Amyloid Angiopathy Using Pharmacological Chaperones to Increase the Activity of Gangliosidases App 20150374733 - Wustman; Brandon Alan ; et al.	2015-12-31
Method for treating alzheimer's disease using pharmacological chaperones to increase the activity of gangliosidases Grant 9,044,437 - Wustman , et al. June 2, 2	2015-06-02
High Concentration Alpha-Glucosidase Compositions for the Treatment of Pompe Disease App 20140193390 - Valenzano; Kenneth ; et al.	2014-07-10
Method for Treating Alzheimer's Disease Using Pharmacological Chaperones To Increase The Activity of Gangliosidases App 20120309788 - Wustman; Brandon ; et al.	2012-12-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.